Sihuan Pharmaceutical Units Sign Cooperation Deal for Weight Loss Drug Distribution

MT NewswiresNov 21 01:47 ET

[Hong Kong Stock Connect] Sihuan Pharm (00460) subsidiary Huisheng Bio and Meiyan Space have reached an exclusive licensing agreement for the weight-loss injection semaglutide.

Jingu Cai Xun | sihuan pharm (00460) announcement, the group's non-wholly owned subsidiary Huisheng Biology and the group's non-wholly owned subsidiary Meiyan Space have reached an exclusive authorization cooperation on the development of semaglutide injection for overweight or obesity adaptation syndrome (collectively referred to as "weight loss") developed by Huisheng Biology. The semaglutide developed by Huisheng Biology is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist, which enhances insulin secretion, inhibits glucagon secretion, delays gastric emptying, increases satiety, reduces appetite and food intake. Not only can it effectively reduce blood sugar levels, but it also has

Jingu Finance NewsNov 20 23:32 ET

Express News | Sihuan Pharma - Unit Entered Exclusive Authorization Cooperation With Meiyan Space for Semaglutide Injection

ReutersNov 20 23:29 ET

Bullish market stimulation boosts Hong Kong healthcare stocks, causing Lai Kai Pharmaceuticals to surge over 18%.

①What bullish news about pharmaceutical stocks has recently been announced in the market? ②How do institutions view the subsequent performance of pharmaceutical stocks?

cls.cnNov 19 22:50 ET

Will the indications of GLP-1 drugs expand to the field of PCOS? The era of three targets is about to arrive? | Industry Observation

①At the GLP-1 Drug Seminar (Chengdu session), participants discussed the global trend of GLP-1 drug research and development. ②Participants mentioned that the indications for GLP-1 drugs in the future may expand to areas such as PCOS and stroke. ③Drugs targeting GLP, GCG, and GIP receptors are beginning to rise.

cls.cnNov 19 08:17 ET

Is Sihuan Pharmaceutical Holdings Group (HKG:460) Weighed On By Its Debt Load?

Simply Wall StNov 15 17:50 ET